This continuing feature focuses on the medication needs of the geriatric population, a group that is especially vulnerable to a variety of medication-related problems (including medication errors). The goals of this series are to increase awareness about the inherent risks and challenges of pharmacologic therapy in elderly patients and to promote optimal medication use in this high-risk population. Questions and comments are appreciated and should be directed to Dianne E. Tobias, PharmD, CGP at detobias@aol.com.
Get full access to this article
View all access options for this article.
References
1.
HeplerC.D., StrandL.M.Opportunities and responsibilities in pharmaceutical care.Am J Hosp Pharm.1990; 47: 533–43.
2.
ClarkT.R., GruberJ., SeyM.Revisiting drug regimen review, Parts 1, 2, and 3.Consult Pharm.2003; 18: 215–20;506–13;657–66.
3.
TobiasD.Adverse events following hospital discharge; assessing and treating hypertension in the geriatric patient: The JNC 7 Report.Hosp Pharm.2003; 10: 919–920,925.
4.
ForsterA.J., MurffH.F., PetersonJ.F.The incidence and severity of adverse events affecting patients after discharge from the hospital.Ann Intern Med.2003; 138: 161–7.
5.
GurwitzJ.H., FieldT.S., HarroldL.R.Incidence and preventability of adverse drug events among older persons in the ambulatory setting.JAMA.2003; 289: 1107–16.
6.
GurwitzJ.H., FieldT.S., AvornJ.Incidence and preventability of adverse drug events in nursing homes.Am J Med.2000; 109: 87–94.
